DIABETIC KETOACIDOSIS (DKA)

โœ“ Medically ReviewedENDOCRINEID: MDBTX0009ICD-11: 5A10
๐Ÿ’ก Core Clinical Guidance

Diabetic Ketoacidosis (DKA) is an acute, life-threatening metabolic emergency characterized by the triad of hyperglycemia, high-anion-gap metabolic acidosis, and ketonemia/ketonuria. It occurs predominantly in Type 1 Diabetes Mellitus due to absolute insulin deficiency or severe stress (infection, infarction), though it can also occur in Type 2 Diabetes under extreme metabolic stress.

๐Ÿ“–

Definition

CLINICAL DEFINITION & PATHOPHYSIOLOGY

Diabetic Ketoacidosis (DKA) is an acute, life-threatening metabolic emergency characterized by the triad of hyperglycemia, high-anion-gap metabolic acidosis, and ketonemia/ketonuria. It occurs predominantly in Type 1 Diabetes Mellitus due to absolute insulin deficiency or severe stress (infection, infarction), though it can also occur in Type 2 Diabetes under extreme metabolic stress.

๐Ÿ’Š

Pharmacological Management โ˜…

โš–๏ธCLINICAL NOTICE & EDUCATIONAL DISCLAIMER

All content in Medobo is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional and local institutional protocols before administering medication or initiating treatment.